Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children

Annals of Pharmacotherapy

Volumn 44, Issue 1, 2010, Pages 35-42

  Miller, Jamie L ^a   Johnson, Peter N ^a   Harrison, Donald L ^a   Hagemann, Tracy M ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Analgesics; Antibiotics; Medication errors; Overweight children; Pediatric

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; COCODAMOL; COTRIMOXAZOLE; FENTANYL; FLUCONAZOLE; GENTAMICIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; IBUPROFEN; KETOROLAC; MEROPENEM; METRONIDAZOLE; MORPHINE; OXACILLIN; PARACETAMOL; PETHIDINE; SULTAMICILLIN; UNINDEXED DRUG;

ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT FAILURE;

ANALGESICS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICATION ERRORS; OVERWEIGHT; RETROSPECTIVE STUDIES;

EID: 74549182660     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M371     Document Type: Article

References (23)

1. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA 2008;299:2401-5. DOI 10.1001/jama.299.20.2401
2. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120(suppl 4): S164-92. DOI 10.542/peds.200/-2329C
3. Centers for Disease Control and Prevention. BMI for children and teens. Atlanta, GA: Centers for Disease Control and Prevention, 2009. www.cdc. gov/nccdphp/dnpa/obesity/childhood/defining.htm (accessed 2008 Jun 30).
4. Koplan JP, Liverman CT, Kraak V, eds. Preventing childhood obesity: health in the balance. Washington, DC: National Academic Press, 2005.
5. Woo JG, Zeller MH, Wilson K, Inge T. Obesity identified by discharge ICD-9 codes underestimates the true prevalence of obesity in hospitalized children. J Pediatr 2009;154:327-31. DOI 10.1016/j.jpeds.2008.09.022
6. Pesaturo KA, Ramsey EZ, Johnson PN, Taylor LM. Introduction into pediatric pharmacy practice: reflections of pediatric practitioners. Am J Health Syst Pharm 2008;65:1314-9. DOI 10.2146/ajhp080009
7. Wong IC, Ghaleb MA, Franklin BD, Barber N. Incidence and nature of dosing errors in paediatric medication: a systematic review. Drug Safety 2004;27:661-70.
8. Stucky ER; American Academy of Pediatrics Committee on Drugs; American Academy of Pediatrics Committee on Hospital Care. Prevention of medication errors in the pediatric inpatient setting. Pediatrics 2003;112:431-6. DOI 10.1542/peds.112.2.431
9. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20. DOI 10.1001/jama.285.16.2114
10. McPhillips HA, Stille CJ, Smith D, et al. Potential medication dosing errors in outpatient pediatrics. J Pediatr 2005;147:761-7. DOI 10.1016/j.jpeds.2005.07.043
11. Ghaleb MA, Barber N, Franklin BD, Yeung VWS, Khaki ZF, Wong ICK. Systematic review of medication errors in pediatric patients. Ann Pharmacother 2006;40:1766-76. Epub 19 Sept 2006. DOI 10.1345/aph.1G717
12. Ross LM, Wallace J, Paton JY. Medication errors in a pediatric teaching hospital in the UK: five years operational experience. Arch Dis Child 2000;83:492-7. DOI 10.1136/adc.83.6.492
13. Marino BL, Reinhardt K, Eichelberger WJ, Steingard R. Prevalence of errors in a pediatric hospital medication system: implications for error proofing. Outcomes Manag Nurs Pract 2000;4:129-35.
14. Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 1987;79:718-22.
15. Bartelink IH, Rademaker CMA, Schobben AF, van den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006;45:1077-97.
16. Department of Health and Human Services Centers for Disease Control and Prevention. BMI calculator for child and teen: metric version. http://apps.nccd.cdc.gov/dnpabmi/Calculator.aspx?CalculatorType =Metric (accessed 2008 Jun 4).
17. Taketomo CK, Hodding JH, Kraus DM. Pediatric dosage handbook. 14th ed. Hudson, OH: Lexi-Comp, Inc., 2007.
18. Micromedex healthcare series [Internet database]. Greenwood Village, CO: Thomson Micromedex. Updated periodically. www.micromedex. com (accessed 2008 Jun 30).
19. SPSS for Windows. Release 14.0. Chicago, IL: SPSS, Inc., 2005.
20. Schwartz SN, Pazin GJ, Lyon JA, Ho M, Pascille AW. A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis 1978;138:499-505.
21. Blouin RA, Mann HJ, Griffen WO, Bauer LA, Record KE. Tobramycin pharmacokinetics in morbidly obese patients. Clin Pharmacol 1979;26: 508-12.
22. Koshida R, Nakashima E, Taniguchi N, Tsuji A, Benet LZ, Ichimura F. Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological pharmacokinetic concepts. Pharm Res 1989;6:486-91.
23. Cheymol G. Effects of obesity on pharmacokinetics: implications for drug therapy. Clin Pharmacokinet 2000;39:215-31.